Bell, D. S. H., & Jerkins, T. (2025). Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease. Archives of Clinical and Biomedical Research, 9(5), 392–395. Retrieved from https://fortunejournals.org/ojs/index.php/acbr/article/view/15136